305 related articles for article (PubMed ID: 28292730)
1. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
[TBL] [Abstract][Full Text] [Related]
2. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
[TBL] [Abstract][Full Text] [Related]
3. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
4. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
Wu C; Jiang J; Shi L; Xu N
Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
8. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.
Niu Q; Wang W; Li Y; Qin S; Wang Y; Wan G; Guan J; Zhu W
Int Immunopharmacol; 2011 Apr; 11(4):449-56. PubMed ID: 21215350
[TBL] [Abstract][Full Text] [Related]
9. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
[TBL] [Abstract][Full Text] [Related]
11. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
Wang M; Cao JX; Pan JH; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
PLoS One; 2014; 9(11):e112662. PubMed ID: 25412106
[TBL] [Abstract][Full Text] [Related]
13. Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.
Li R; Wang C; Liu L; Du C; Cao S; Yu J; Wang SE; Hao X; Ren X; Li H
Cancer Immunol Immunother; 2012 Nov; 61(11):2125-33. PubMed ID: 22581306
[TBL] [Abstract][Full Text] [Related]
14. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
Xu YC; Xu Q; Li JJ; Gu XF; Lin XL; Sun L; Lu HM; Tang L; Ma Y; Lu Z; Wang HX
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1315-23. PubMed ID: 26941189
[TBL] [Abstract][Full Text] [Related]
16. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.
Luo H; Gong L; Zhu B; Huang Y; Tang C; Yu S; Yang Z; Zhou X
Biomed Pharmacother; 2016 Dec; 84():987-993. PubMed ID: 27764762
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery.
Li H; Wang C; Yu J; Cao S; Wei F; Zhang W; Han Y; Ren XB
Cytotherapy; 2009; 11(8):1076-83. PubMed ID: 19929470
[TBL] [Abstract][Full Text] [Related]
19. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.
Ren J; Di L; Song G; Yu J; Jia J; Zhu Y; Yan Y; Jiang H; Liang X; Che L; Zhang J; Wan F; Wang X; Zhou X; Lyerly HK
Clin Transl Oncol; 2013 Oct; 15(10):780-8. PubMed ID: 23359185
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.
Ding X; Cao H; Chen X; Jin H; Liu Z; Wang G; Cai L; Li D; Niu C; Tian H; Yang L; Zhao Y; Li W; Cui J
J Transl Med; 2015 May; 13():158. PubMed ID: 25968637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
